FFA
TMO icon

Freedman Financial Associates’s Thermo Fisher Scientific TMO Stock Holding History

Freedman Financial Associates’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-371
Closed -$219K – 378
2022
Q1 		$219K Buy
371
+10
+3% +$5.74K 0.15% 74
2021
Q4 		$241K Hold
361
– – 0.16% 64
2021
Q3 		$206K Hold
361
– – 0.15% 67
2021
Q2 		$182K Hold
361
– – 0.14% 72
2021
Q1 		$165K Hold
361
– – 0.14% 70
2020
Q4 		$168K Buy
+361
New +$169K 0.15% 63

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Freedman Financial Associates's TMO Position: Q2 2022 in Review

Freedman Financial Associates sold out of Thermo Fisher Scientific (TMO) in Q2 2022, closing a stake of 371 shares — an estimated $219K sold.

Freedman Financial Associates first reported a position in TMO in Q4 2020 and held it in 6 quarters. The position peaked at $241K in Q4 2021. 2,281 funds tracked by Wall St. Rank hold TMO as of Q2 2022.

  • Freedman Financial Associates reported no remaining Thermo Fisher Scientific position as of Q2 2022 after selling out during the quarter.
  • Freedman Financial Associates sold 371 Thermo Fisher Scientific shares in Q2 2022, an estimated $219K.
  • Freedman Financial Associates first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 6 quarters.
  • Freedman Financial Associates's Thermo Fisher Scientific position peaked at $241K in Q4 2021.
  • 2,281 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2022.

Based on Freedman Financial Associates's 13F filing for Q2 2022.